Literature DB >> 17430232

Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study.

Philip A Wolf1, Alexa Beiser, Merrill F Elias, Rhoda Au, Ramachandran S Vasan, Sudha Seshadri.   

Abstract

BACKGROUND: Obesity has been related to the incidence of dementia but its impact on cognitive performance in persons without dementia is less clear. We hypothesized that mid-life obesity may modulate the impact of conventional cardiovascular risk factors (CVRF) on cognitive impairment. We tested this hypothesis in the community-based Framingham Offspring Study sample.
METHODS: At Examination cycle 4 (1988-90) of the Offspring Cohort, indices of obesity (BMI and Waist-Hip Ratio [WHR]) and baseline CVRF levels were ascertained in 1,814 men and women, aged 40-69 years. Obesity and hypertension were related to the score on each of 8 neurocognitive tests measured at Examination 8, 12 years later (1999-2002).
RESULTS: Midlife measures of central obesity (WHR in the uppermost quartile- Q4) and of hypertension (BP > or = 140 / > or = 90 or use of anti-hypertensive medication) were each significantly related to poorer performance on executive function & visuomotor skills (Trails B, Visual Reproductions-Immediate and Delayed Recall). Further, the relation of hypertension to neurocognitive performance was significantly modified by WHR; hypertension was not associated with neurocognitive performance in WHR Q1-Q3, but was associated with a marked adverse performance in Q4 WHR. Neither HTN nor obesity was individually or synergistically related to verbal memory (immediate or delayed recall).
CONCLUSIONS: Executive function and visuomotor skills were differentially affected by the combined presence of midlife hypertension and Q4 WHR while measures of verbal memory function were not related to these risk factors in our sample, a pattern consistent with vascular cognitive impairment. Control of mid-life elevated blood pressure and central obesity may be strategies to reduce cognitive decline with age.

Entities:  

Mesh:

Year:  2007        PMID: 17430232     DOI: 10.2174/156720507780362263

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  108 in total

1.  P300 and the stroop effect in overweight minority adolescents.

Authors:  Lance O Bauer; Richard F Kaplan; Victor M Hesselbrock
Journal:  Neuropsychobiology       Date:  2010-03-18       Impact factor: 2.328

2.  Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure.

Authors:  David Zade; Alexa Beiser; Regina McGlinchey; Rhoda Au; Sudha Seshadri; Carole Palumbo; Philip A Wolf; Charles DeCarli; William Milberg
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-08-10       Impact factor: 2.136

Review 3.  Can bariatric surgery reduce risk of Alzheimer's disease?

Authors:  Kelly M Stanek; John Gunstad
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-07-04       Impact factor: 5.067

Review 4.  Brain health and shared risk factors for dementia and stroke.

Authors:  Hannah Gardener; Clinton B Wright; Tatjana Rundek; Ralph L Sacco
Journal:  Nat Rev Neurol       Date:  2015-10-20       Impact factor: 42.937

Review 5.  The relationship between blood pressure and cognitive function.

Authors:  Vera Novak; Ihab Hajjar
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

6.  Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism.

Authors:  Outi Heikkilä; Nina Lundbom; Marjut Timonen; Per-Henrik Groop; Sami Heikkinen; Sari Mäkimattila
Journal:  Metab Brain Dis       Date:  2008-07-22       Impact factor: 3.584

7.  Interactive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes.

Authors:  David Zade; Alexa Beiser; Regina McGlinchey; Rhoda Au; Sudha Seshadri; Carole Palumbo; Philip A Wolf; Charles Decarli; William Milberg
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-05-14       Impact factor: 2.136

8.  Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study.

Authors:  Séverine Sabia; Mika Kivimaki; Martin J Shipley; Michael G Marmot; Archana Singh-Manoux
Journal:  Am J Clin Nutr       Date:  2008-12-10       Impact factor: 7.045

Review 9.  Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

10.  Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.

Authors:  Wolfgang Lieb; Alexa S Beiser; Ramachandran S Vasan; Zaldy S Tan; Rhoda Au; Tamara B Harris; Ronenn Roubenoff; Sanford Auerbach; Charles DeCarli; Philip A Wolf; Sudha Seshadri
Journal:  JAMA       Date:  2009-12-16       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.